118 related articles for article (PubMed ID: 7689342)
1. Plasminogen activators and plasminogen activator inhibitors in connective tissues and connective tissue cells: influence of the neuropeptide substance P on expression.
Murphy PG; Hart DA
Biochim Biophys Acta; 1993 Sep; 1182(2):205-14. PubMed ID: 7689342
[TBL] [Abstract][Full Text] [Related]
2. Influence of exogenous growth factors on the expression of plasminogen activators and plasminogen activator inhibitors by cells isolated from normal and healing rabbit ligaments.
Murphy PG; Hart DA
J Orthop Res; 1994 Jul; 12(4):564-75. PubMed ID: 7520487
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the plasminogen activators and plasminogen activator inhibitors expressed by cells isolated from rabbit ligament and synovial tissues: evidence for unique cell populations.
Murphy PG; Frank CB; Hart DA
Exp Cell Res; 1993 Mar; 205(1):16-24. PubMed ID: 8453990
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts.
Xiao Y; Bunn CL; Bartold PM
J Periodontal Res; 1998 Jan; 33(1):17-26. PubMed ID: 9524317
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis.
Saxne T; Lecander I; Geborek P
J Rheumatol; 1993 Jan; 20(1):91-6. PubMed ID: 8441174
[TBL] [Abstract][Full Text] [Related]
6. Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium.
Pelletier JP; McCollum R; Cloutier JM; Martel-Pelletier J
Br J Rheumatol; 1992; 31 Suppl 1():19-26. PubMed ID: 1555050
[TBL] [Abstract][Full Text] [Related]
7. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.
Hu ZY; Liu YX; Liu K; Byrne S; Ny T; Feng Q; Ockleford CD
J Anat; 1999 Feb; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of plasminogen activator and plasminogen activator inhibitor by osteotropic factors in primary cultures of mature osteoblasts and osteoblast precursors.
Pfeilschifter J; Erdmann J; Schmidt W; Naumann A; Minne HW; Ziegler R
Endocrinology; 1990 Feb; 126(2):703-11. PubMed ID: 2298166
[TBL] [Abstract][Full Text] [Related]
9. Regulation of plasminogen activator activity in arthritic joints.
Hamilton JA; Hart PH; Leizer T; Vitti GF; Campbell IK
J Rheumatol Suppl; 1991 Feb; 27():106-9. PubMed ID: 1902874
[TBL] [Abstract][Full Text] [Related]
10. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
[TBL] [Abstract][Full Text] [Related]
11. Expression of plasminogen activator and plasminogen activator inhibitor by rat mesothelioma induced by asbestos.
Lenz SP; Green FH; Murphy PG; Lee M; Hart DA
Cancer Lett; 1993 Feb; 68(2-3):119-27. PubMed ID: 8443784
[TBL] [Abstract][Full Text] [Related]
12. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
Gross TJ; Sitrin RG
J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
[TBL] [Abstract][Full Text] [Related]
13. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
15. Influence of exogenous growth factors on the expression of plasminogen activators by explants of normal and healing rabbit ligaments.
Murphy PG; Loitz BJ; Frank CB; Hart DA
Biochem Cell Biol; 1993; 71(11-12):522-9. PubMed ID: 8192890
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
Fukumoto S; Allan EH; Yee JA; Gelehrter TD; Martin TJ
J Cell Physiol; 1992 Aug; 152(2):346-55. PubMed ID: 1322417
[TBL] [Abstract][Full Text] [Related]
17. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase.
Gross TJ; Simon RH; Kelly CJ; Sitrin RG
Am J Physiol; 1991 Apr; 260(4 Pt 1):L286-95. PubMed ID: 1902065
[TBL] [Abstract][Full Text] [Related]
18. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
Schleef RR; Podor TJ; Dunne E; Mimuro J; Loskutoff DJ
J Cell Biol; 1990 Jan; 110(1):155-63. PubMed ID: 2104856
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage.
Martel-Pelletier J; Zafarullah M; Kodama S; Pelletier JP
J Rheumatol Suppl; 1991 Feb; 27():80-4. PubMed ID: 1851231
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
Medcalf RL; Van den Berg E; Schleuning WD
J Cell Biol; 1988 Mar; 106(3):971-8. PubMed ID: 3126194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
